Goldman Sachs Group Inc Amarin Corp Plcuk Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Goldman Sachs Group Inc holds 332,111 shares of AMRN stock, worth $192,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
332,111
Previous 388,511
14.52%
Holding current value
$192,624
Previous $345,000
33.62%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AMRN
# of Institutions
187Shares Held
76.6MCall Options Held
247KPut Options Held
121K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$14.4 Million2.89% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.2MShares$7.05 Million0.65% of portfolio
-
Dg Capital Management, LLC New York, NY5.12MShares$2.97 Million1.36% of portfolio
-
Eversept Partners, LP New York, NY4.31MShares$2.5 Million0.22% of portfolio
-
Two Sigma Investments, LP New York, NY3.04MShares$1.76 Million0.01% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $234M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...